Optimum Investor Survey 2024

The must attend healthcare conferences in Winter/Spring 2024

Where has the time gone? We are now in 2024 and industry events are quickly approaching.  If you are still gathering your thoughts on how best to maximise your time in 2024, allow us to flag the ‘must-attend’ Healthcare conferences of Winter/Spring 2024.    January is for JPM  The 42nd JPM Annual Healthcare Conference: 8th-11th January, San Francisco, […]

Optimum’s chosen charity: Ariana Smiles

In October, at our 15th Annual Healthcare Investor Conference, we announced our chosen charity for the year, Ariana Smiles. Ariana Smiles is a Special Named Fund at the Children’s Cancer and Leukaemia Group, raising funds for research into precision oncology medicine for children with leukaemia. Stephanie Seales Gabbitas and her husband Chris set up Ariana […]

Optimum’s Year-End Review  

2023 was an exciting year for Optimum’s clients who overcame many of the market challenges to make significant strides forward with their vital life sciences research. Here are some of the highlights from what has been an exceptionally busy and successful year.   M&A & deals Synaffix continued to build momentum – Lonza acquired the […]

A history of closed loop systems in type 1 diabetes

Replacing the lost function of the pancreas is the “holy grail” of treatments for type 1 diabetes, where the body becomes unable to produce the insulin it needs to regulate blood sugar levels. But the technology to do this has actually been around since the 1960s – it’s just been impractical to use on a […]